tada, from your lips (um, typing fingers) to god's ears ... I'm in it till interim analysis at the very least, but sooner would certainly be better. C'mon Don, make it rain.

" Back to the beginning, the paradym shift. IF and that's a big if, an offer or partnership is made and accepted, the business side of this investment changes forever. That seems to be where the biggest challenges are coming from. There was a comment in the last couple of days that the strength of the BOD seems a little week and easily manipulated, that would change almost immediately. It would be responsable for any BP stepping in as a partner who is putting up some significant cash to request and receive 1 or 2 seats on the board. In order to make room for them 1 or 2 of the existing board members would be required to step down. The consiquence of that is instant strengthing of the board. Maybe just maybe that would be the trigger that would encourage DM to step aside as Pres/CEO and remain as Chairman of the Board. The result of all of this is win, win, win. The science wins by having the funds to prove what they beleive it can do, the BP wins by bringing this new science with a BTD to maket and most of all for you and I, the shareholders win.

The catalyst to set this all in motion is in the process of happening as we sit here, starting the COVID trial and having some success in that short trial.

There appears to be enough ducks lined up to get us through to May, IMO it wont take that long for one of those BP's to pull the trigger on either a partnership or outright takeover. "